Oruka Therapeutics (ORKA) Interest & Investment Income (2009 - 2026)
Oruka Therapeutics (ORKA) posted Interest & Investment Income of $444,000 for Q2 2024, down 9.9% from $493,000 a year earlier and down 6.1% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Interest & Investment Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2024, Interest & Investment Income at Oruka Therapeutics was $1.93 million, up 25.5% year-over-year; for FY2023, it came in at $1.96 million, up 189.9% from FY2022.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 64.6% (FY2018 to FY2023).
- In prior years, Oruka Therapeutics' Interest & Investment Income was $675,000 in FY2022, $13,000 in FY2021 (-53.6%), $28,000 in FY2020 (-83.7%) and $172,000 in FY2019 (+6.2%).
- The Q2 2024 figure stands as the lowest quarterly Interest & Investment Income since Q4 2022.
- On a year-over-year basis, Interest & Investment Income increased in four of the last five quarters, with growth averaging 149.0%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 584.7%; the weakest was Q3 2020, with a decline of 98.0%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $473,000 (Q1 2024), $501,000 (Q4 2023) and $513,000 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Oruka Therapeutics | 7.43 Bn | 4.55 Bn | - | 12.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.17 Mn |
| Jun 30, 2026 | 8.90 Mn |
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 4.85 Mn |
| Sep 30, 2025 | 3.83 Mn |
| Jun 30, 2025 | 3.86 Mn |
| Mar 31, 2025 | 4.09 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 513,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 72,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 4,000.00 |
API Access
Oruka Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();